<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Breast Cancer Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 30 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Thu, 30 May 2013 11:43:49 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>Sorting Through the Arguments on Breast Screening Arguments for or Against Breast Screening </title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1691913</link>
      <pubDate>Thu, 30 May 2013 00:00:00 GMT</pubDate>
      <author>Marmot MG. </author>
      <description>&lt;span class="paragraphSection"&gt;Views on the benefits and harms of breast cancer screening are sharply polarized and increasingly vocal. Allegations of harming women are flung in both directions. The antiscreeners claim that benefit is minimal and overdiagnosis is so frequent that women are being subject to unnecessary interventions and treatment. The proscreeners claim that if the critics win the day, women will be deprived of the benefits that screening brings of early diagnosis and reductions in mortality from breast cancer.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.6822</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1691913</guid>
    </item>
    <item>
      <title>Breast Cancer Screening Conflicting Guidelines and Medicolegal Risk  Breast Cancer Screening </title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1691914</link>
      <pubDate>Thu, 30 May 2013 00:00:00 GMT</pubDate>
      <author>Kachalia A, Mello MM. </author>
      <description>&lt;span class="paragraphSection"&gt;There is considerable inconsistency and controversy in today's guidelines regarding breast cancer screening. Although the presence of a wide range of professionally endorsed options arguably gives physicians a broader set of clinically valid choices, these options may paradoxically leave clinicians feeling more exposed to claims of malpractice.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.7100</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1691914</guid>
    </item>
  </channel>
</rss>